News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
143,150 Results
Type
Article (8501)
Company Profile (61)
Press Release (134588)
Multimedia
Podcasts (12)
Webinars (2)
Section
Business (41837)
Career Advice (160)
Deals (6543)
Drug Delivery (10)
Drug Development (27879)
Employer Resources (18)
FDA (3821)
Job Trends (4036)
News (78117)
Policy (5620)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (436)
Accelerated approval (2)
Adcomms (11)
Allergies (12)
Alliances (12056)
ALS (14)
Alzheimer's disease (248)
Antibody-drug conjugate (ADC) (102)
Approvals (3864)
Artificial intelligence (90)
Autoimmune disease (4)
Automation (3)
Bankruptcy (62)
Best Places to Work (3761)
BIOSECURE Act (1)
Biosimilars (38)
Biotechnology (53)
Bladder cancer (64)
Brain cancer (23)
Breast cancer (211)
Cancer (1670)
Cardiovascular disease (47)
Career advice (134)
Career pathing (5)
CAR-T (72)
Cell therapy (169)
Cervical cancer (13)
Clinical research (23532)
Collaboration (362)
Compensation (118)
Complete response letters (1)
COVID-19 (388)
CRISPR (12)
C-suite (93)
Cystic fibrosis (4)
Data (912)
Decentralized trials (1)
Depression (9)
Diabetes (33)
Diagnostics (1568)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (46)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (15)
Earnings (14644)
Editorial (11)
Employer branding (3)
Employer resources (18)
Events (25872)
Executive appointments (263)
FDA (4213)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (178)
Gene editing (25)
Generative AI (8)
Gene therapy (63)
GLP-1 (126)
Government (676)
Grass and pollen (1)
Guidances (16)
Healthcare (4649)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (33)
Indications (17)
Infectious disease (409)
Inflammatory bowel disease (34)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (27)
Interviews (26)
IPO (3266)
IRA (7)
Job creations (510)
Job search strategy (117)
Kidney cancer (11)
Labor market (3)
Layoffs (132)
Leadership (6)
Legal (567)
Liver cancer (45)
Lung cancer (274)
Lymphoma (92)
Machine learning (3)
Management (6)
Manufacturing (49)
MASH (7)
Medical device (1276)
Medtech (1277)
Mergers & acquisitions (3425)
Metabolic disorders (95)
Multiple sclerosis (19)
NASH (4)
Neurodegenerative disease (9)
Neuropsychiatric disorders (2)
Neuroscience (360)
NextGen: Class of 2025 (1139)
Non-profit (668)
Northern California (916)
Now hiring (7)
Obesity (54)
Opinion (40)
Ovarian cancer (58)
Pain (7)
Pancreatic cancer (55)
Parkinson's disease (29)
Partnered (1)
Patents (46)
Patient recruitment (33)
Peanut (6)
People (13985)
Pharmaceutical (14)
Pharmacy benefit managers (1)
Phase I (8297)
Phase II (9982)
Phase III (7706)
Pipeline (455)
Policy (18)
Postmarket research (735)
Preclinical (2641)
Press Release (3)
Prostate cancer (82)
Psychedelics (3)
Radiopharmaceuticals (163)
Rare diseases (76)
Real estate (791)
Recruiting (7)
Regulatory (4968)
Reports (9)
Research institute (734)
Resumes & cover letters (23)
Rett syndrome (1)
RSV (8)
Schizophrenia (19)
Series A (37)
Series B (11)
Service/supplier (1)
Sickle cell disease (19)
Southern California (754)
Special edition (1)
Spinal muscular atrophy (19)
Sponsored (3)
Startups (805)
State (1)
Stomach cancer (10)
Supply chain (7)
Tariffs (5)
The Weekly (12)
United States (6779)
Vaccines (135)
Venture capitalists (13)
Weight loss (26)
Women's health (2)
Worklife (1)
Date
Today (43)
Last 7 days (304)
Last 30 days (883)
Last 365 days (10240)
2025 (3272)
2024 (10914)
2023 (12188)
2022 (14775)
2021 (15090)
2020 (12731)
2019 (10111)
2018 (7400)
2017 (8024)
2016 (7026)
2015 (7956)
2014 (5212)
2013 (3569)
2012 (3839)
2011 (3816)
2010 (3518)
Location
Africa (97)
Alabama (20)
Alaska (2)
Arizona (23)
Arkansas (2)
Asia (11485)
Australia (1560)
California (1925)
Canada (475)
China (291)
Colorado (67)
Connecticut (77)
Delaware (108)
Europe (22000)
Florida (275)
Georgia (21)
Idaho (11)
Illinois (178)
India (9)
Indiana (71)
Iowa (4)
Japan (74)
Kansas (9)
Kentucky (10)
Maine (5)
Maryland (236)
Massachusetts (1554)
Michigan (23)
Minnesota (74)
Missouri (13)
Montana (8)
Nebraska (6)
Nevada (15)
New Hampshire (11)
New Jersey (534)
New Mexico (3)
New York (501)
North Carolina (208)
Northern California (916)
Ohio (53)
Oklahoma (1)
Oregon (7)
Pennsylvania (337)
Rhode Island (4)
South America (137)
South Carolina (3)
Southern California (754)
Tennessee (24)
Texas (294)
Utah (47)
Virginia (19)
Washington D.C. (16)
Washington State (173)
Wisconsin (12)
143,150 Results for "elevation oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Elevation Mulls Strategic Alternatives, Including Closure, Amid Activist Pressure
BML Capital Management, an activist investor that owns 9.9% of Elevation’s shares, is urging the company to wind down operations given “the current state of the public equity market.”
April 18, 2025
·
2 min read
·
Tristan Manalac
Genetown
Elevation Oncology to Present at the Citizens JMP Life Sciences Conference 2024
Elevation Oncology, Inc. announced that Joseph J. Ferra, Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 11:30 am ET.
May 7, 2024
·
1 min read
Genetown
Elevation Oncology to Participate in Upcoming Investor Conferences
Elevation Oncology, Inc. today announced that members of management will participate in upcoming investor conferences in March.
February 28, 2024
·
1 min read
Drug Development
Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer
Elevation Oncology, Inc. announced plans to expand its ongoing Phase 1 clinical trial to include two combination cohorts evaluating EO-3021 for the treatment of advanced gastric or gastroesophageal junction cancer.
June 27, 2024
·
8 min read
Business
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
Elevation Oncology, Inc. today announced financial results for the quarter ended March 31, 2024, and highlighted recent business achievements.
May 2, 2024
·
8 min read
Press Releases
Bacteria in Our Aging Guts Can Elevate Risk of Leukemia
April 24, 2025
·
7 min read
Drug Development
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Elevation Oncology, Inc. (Nasdaq: ELEV) today announced new preclinical data demonstrating proof-of-concept for its differentiated HER3-ADC program.
April 8, 2024
·
5 min read
Genetown
Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced program updates and upcoming 2024 milestones.
January 5, 2024
·
7 min read
Business
Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
Elevation Oncology, Inc. today announced the appointment of Darcy Mootz, Ph.D., to its Board of Directors.
January 22, 2024
·
5 min read
Business
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
Elevation Oncology, Inc. today announced financial results for the quarter and full-year ended December 31, 2023, and highlighted recent business achievements.
March 6, 2024
·
10 min read
1 of 14,315
Next
